Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
DULAGLUTIDE , Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide
Eli Lilly Co.
Type 2 Diabetes Mellitus
1 trial -
Mirikizumab, Tirzepatide, to match Tirzepatide, Tirzepatide, Tirzepatide, Mirikizumab, Tirzepatide, Tirzepatide, Tirzepatide
Eli Lilly Co.
Obesity or Overweight, Ulcerative Colitis
1 trial -
Retatrutide, Tirzepatide, Retatrutide, Tirzepatide, Tirzepatide, Tirzepatide, Retatrutide, Retatrutide, Retatrutide, Tirzepatide, Tirzepatide
Eli Lilly Co.
Obesity
1 trial -
TIRZEPATIDE, TIRZEPATIDE, Retatrutide, Retatrutide, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, Retatrutide, Retatrutide, TIRZEPATIDE, Placebo to match LY, Retatrutide, Placebo to match LY
Eli Lilly Co.
Metabolic Dysfunction-Associated Steatotic Liver Disease
1 trial -
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, Placebo to match LY3298176, TIRZEPATIDE, TIRZEPATIDE
Eli Lilly Co.
Obesity, Overweight
1 trial -
Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Mirikizumab, Mirikizumab, to match Tirzepatide, Tirzepatide, Mirikizumab, Tirzepatide
Eli Lilly Co.
Obesity or Overweight, Crohnβs Disease
1 trial -
Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Placebo to match LY3298176 injection
Eli Lilly Co.
Obesity
1 trial -
TIRZEPATIDE, TIRZEPATIDE, Placebo to match LY3298176, TIRZEPATIDE, IOHEXOL , TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE
Eli Lilly Co.
Chronic Kidney Disease, CKD, Obesity, Overweight, T2D, Type 2 Diabetes
1 trial -
Tirzepatide
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
Tirzepatide
Regeneron UK Limited
Obesity
1 trial -
Tirzepatide
BRIGHT MINDS BIOSCIENCES INC.
Cannabis Use Disorder
1 trial -
Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Nisotirotide, placebo to match LY, Tirzepatide
Eli Lilly Co.
Type 2 Diabetes
1 trial -
Tirzepatide
First Tracks Biotherapeutics
Type 2 Diabetes Mellitus
1 trial -
Tirzepatide
Grace Therapeutics
Prader-Willi Syndrome
1 trial -
Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
First Tracks Biotherapeutics
Diabetes
1 trial -
Tirzepatide
United Therapeutics Europe Ltd
Hypertension
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources